Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 15;116(18):4402-9.
doi: 10.1002/cncr.25389.

Timing of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study

David Hui  1 , Henrique Parsons, Linh Nguyen, Shana L Palla, Sriram Yennurajalingam, Razelle Kurzrock, Eduardo Bruera
Affiliations

Timing of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study

David Hui et al. Cancer. .

Abstract

Background: Phase 1 trials offer patients with advanced cancer the opportunity to pursue life-prolonging cancer treatments. In the current study, the timing of referral and symptom burden between patients referred to palliative care by phase 1 oncologists and those referred by non-phase 1 oncologists were compared.

Methods: All 57 patients with advanced solid tumors who were referred by phase 1 oncologists to the palliative care outpatient clinic at The University of Texas M. D. Anderson Cancer Center (MDACC) between 2007 and 2008 were included. The comparison cohort was comprised of 114 non-phase 1 patients who were stratified by age, sex, and cancer diagnosis in a 1:2 ratio. Information regarding patient characteristics, Edmonton Symptom Assessment Scale (ESAS), timing of referral, and survival was retrieved.

Results: Both cohorts had the following matched characteristics: average age of 57 years, with 44% of the patients being female and 47% having gastrointestinal cancers. At the time of palliative care consultation, patients referred by phase 1 oncologists were more likely than patients referred by non-phase 1 oncologists to have a better performance status (Eastern Cooperative Oncology Group 0-1: 61% vs 36% [P = .003). The ESAS was not significantly different with the exception of better well-being in the phase 1 cohort (mean, 4.5 vs 5.5; P = .03). No difference was found for the duration between registration at MDACC and palliative care consultation (13 months vs 11 months; P = .41) and overall survival from the time of palliative care consultation (5 months vs 4 months; P = .69).

Conclusions: Outpatients referred to palliative care by phase 1 oncologists were found to have a better performance status but similar symptom burden compared with patients referred by non-phase 1 oncologists. Patients with phase 1 involvement did not appear to have delayed palliative care referral compared with non-phase 1 patients. The results of the current study support the development of a simultaneous care model.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Timing of Palliative Care Referral
Kaplan-Meir curves for (A) Interval between M.D. Anderson registration and palliative care consultation, and (B) Interval between palliative care consultation and death
See this image and copyright information in PMC

References

    1. Tishelman C, Petersson LM, Degner LF, et al. Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death. J Clin Oncol. 2007;25:5381–5389. - PubMed
    1. Portenoy RK, Thaler HT, Kornblith AB, et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res. 1994;3:183–189. - PubMed
    1. Cox K. Informed consent and decision-making: Patients’ experiences of the process of recruitment to phases I and II anti-cancer drug trials. Patient Educ Couns. 2002;46:31–38. - PubMed
    1. Cohen MZ, Slomka J, Pentz RD, et al. Phase I participants’ views of quality of life and trial participation burdens. Support Care Cancer. 2007;15:885–890. - PubMed
    1. Cox K. Enhancing cancer clinical trial management: Recommendations from a qualitative study of trial participants’ experiences. Psychooncology. 2000;9:314–322. - PubMed

Publication types